Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medication
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
37m
Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...
AFP
6h
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
Los Angeles wildfire updates
Apologizes for old tweets
Top leaders asked to resign
Cause of death revealed
Olympic gold medalist dies
Sexual misconduct accusation
Recuses self from Act 10 suit
Inmate's transfer blocked
2 more victims in indictment
'As Tears Go By' singer dies
Confirmed interior secretary
FDA approves painkiller
Asteroid may hit Earth
Ground stop amid IT outage
Partners w/ US national labs
Hamas confirms death
Michigan priest loses license
DOJ sues to block deal
Nashville bids for franchise
Signs education orders
Shiffrin finishes 10th
Weekly jobless claims fall
Ex-worker admits to theft
S3 release date revealed
Blames DEI for crash
US economy grew 2.3%
Deputy shooting sentence
Ebola outbreak in Uganda
Feedback